Skip to main content

Table 3 Time schedule

From: A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)

 

TRIAL PERIOD

FOLLOW-UP

Screening visit

Pre-study

During study

Year 1

Year 2

Year 3 till ∞

  

Every SABR fraction

Last day of SABR

3 months after SABR

6 months after SABR

Every 3 months

Every 6 months

yearly

Informed consent

x

        

Clinical examination

x

  

x

x

x

x

x

x

Registration of toxicity

 

x

 

x

x

x

x

x

x

Registration of QoL

 

x

 

x

x

x

x

x

x

Blood sample

 

x

x

x

x

x

   

Imaging

     

x

   
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us